Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Why Manchester United Stock Soared This Week: https://g.foolcdn.com/editorial/images/736503/soccer-fans-at-stadium.jpg
Why Manchester United Stock Soared This Week

The long, drawn-out sale of English Premier League club Manchester United (NYSE: MANU) seems to be nearing an end, and if reports are to be believed, shareholders will get a payout. The excitement

Why MicroVision Stock Is Skyrocketing Today: https://g.foolcdn.com/editorial/images/736454/a-rocket-launching-from-a-persons-hand.jpg
Why MicroVision Stock Is Skyrocketing Today

Shares of MicroVision (NASDAQ: MVIS) are soaring in Thursday's trading. The machine-vision specialist's stock was up 14.1% at 10:30 a.m. ET, according to data from S&P Global Market Intelligence.

Earn Dividends EVERY Month With These 3 Stocks: https://g.foolcdn.com/editorial/images/736397/youtube-thumbnails-50.png
Earn Dividends EVERY Month With These 3 Stocks

You can earn monthly dividend income in a few ways:

Today, I look at three blue chip stocks that are trading at reasonable valuations and will have you receiving a dividend paycheck every month. One

Earn Dividends EVERY Month With These 3 Stocks: https://g.foolcdn.com/editorial/images/736397/youtube-thumbnails-50.png
Earn Dividends EVERY Month With These 3 Stocks

You can earn monthly dividend income in a few ways:

Today, I look at three blue chip stocks that are trading at reasonable valuations and will have you receiving a dividend paycheck every month. One

2 Stocks Down 11% and 20% to Buy Right Now: https://g.foolcdn.com/editorial/images/736303/gettyimages-investor-uses-tablet-and-phone.jpg
2 Stocks Down 11% and 20% to Buy Right Now

When looking for bargains at a store, you might go to the sale rack. With the stock market, you might look to some of the stocks that have tumbled over the past several months. Even though the three

2 Stocks Down 11% and 20% to Buy Right Now: https://g.foolcdn.com/editorial/images/736303/gettyimages-investor-uses-tablet-and-phone.jpg
2 Stocks Down 11% and 20% to Buy Right Now

When looking for bargains at a store, you might go to the sale rack. With the stock market, you might look to some of the stocks that have tumbled over the past several months. Even though the three

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
2 Growth Stocks Cathie Wood Is Buying Hand Over Fist: https://g.foolcdn.com/editorial/images/736297/investors-evaluating-a-stock-purchase-getty.jpg
2 Growth Stocks Cathie Wood Is Buying Hand Over Fist

Artificial intelligence (AI) is getting heaps of attention on Wall Street, but that doesn't mean it's the only innovative investment opportunity right now. Shares of plenty of companies that aren't

Why Shares of UnitedHealth Group Are Dropping Wednesday: https://g.foolcdn.com/editorial/images/736389/group-of-medical-practitioners-having-a-seminar-in-board-room.jpg
Why Shares of UnitedHealth Group Are Dropping Wednesday

Shares of healthcare insurer UnitedHealth Group (NYSE: UNH) were down more than 7% Wednesday afternoon after falling as much as 9.3% earlier in the day. The drop in the stock came after comments by

Why Shares of UnitedHealth Group Are Dropping Wednesday: https://g.foolcdn.com/editorial/images/736389/group-of-medical-practitioners-having-a-seminar-in-board-room.jpg
Why Shares of UnitedHealth Group Are Dropping Wednesday

Shares of healthcare insurer UnitedHealth Group (NYSE: UNH) were down more than 7% Wednesday afternoon after falling as much as 9.3% earlier in the day. The drop in the stock came after comments by

These 2 Small Nasdaq Tech Stocks Punished Investors Wednesday: https://g.foolcdn.com/editorial/images/736373/camera-lens-gettyimages-1187951204.jpg
These 2 Small Nasdaq Tech Stocks Punished Investors Wednesday

The prevailing mood lately on Wall Street has been positive. That has sent a lot of individual stocks higher over the past several weeks, particularly those with technology connections.

Why Centene, CVS Health, and Humana Stocks Are Sinking Today: https://g.foolcdn.com/editorial/images/736328/hospital-surgery-nurses-prep-bed.jpg
Why Centene, CVS Health, and Humana Stocks Are Sinking Today

Shares of several health insurers were sinking on Wednesday. Centene (NYSE: CNC) stock was down 7.9% as of 12:13 p.m. ET, while CVS Health (NYSE: CVS) and Humana (NYSE: HUM) shares were falling 6.1%

Why Centene, CVS Health, and Humana Stocks Are Sinking Today: https://g.foolcdn.com/editorial/images/736328/hospital-surgery-nurses-prep-bed.jpg
Why Centene, CVS Health, and Humana Stocks Are Sinking Today

Shares of several health insurers were sinking on Wednesday. Centene (NYSE: CNC) stock was down 7.9% as of 12:13 p.m. ET, while CVS Health (NYSE: CVS) and Humana (NYSE: HUM) shares were falling 6.1%

Why MicroVision Stock Slumped on Wednesday: https://g.foolcdn.com/editorial/images/736322/delivery-driver-using-gps.jpg
Why MicroVision Stock Slumped on Wednesday

MicroVision (NASDAQ: MVIS) shareholders continue to see elevated volatility in their portfolios. The computer vision tech specialist's shares were down by 23% as of 10:45 a.m. Wednesday, reversing

2 Healthcare Stocks That Could Make You Richer: https://g.foolcdn.com/editorial/images/735694/physicians-in-an-operating-room.jpg
2 Healthcare Stocks That Could Make You Richer

According to an old proverb, good things come to those who wait. That tends to be true in the stock market, at least for investors who buy shares of quality companies. Waiting, being patient, and

Where Will CRISPR Therapeutics Be in 10 Years?: https://g.foolcdn.com/editorial/images/735989/dna-sequencing-genome-science-lab.jpg
Where Will CRISPR Therapeutics Be in 10 Years?

Investor enthusiasm can wax and wane -- sometimes dramatically. Consider CRISPR Therapeutics (NASDAQ: CRSP), which is trading for around $61 a share, down from its high of $220.20 on Jan. 15, 2021.

Where Will CRISPR Therapeutics Be in 10 Years?: https://g.foolcdn.com/editorial/images/735989/dna-sequencing-genome-science-lab.jpg
Where Will CRISPR Therapeutics Be in 10 Years?

Investor enthusiasm can wax and wane -- sometimes dramatically. Consider CRISPR Therapeutics (NASDAQ: CRSP), which is trading for around $61 a share, down from its high of $220.20 on Jan. 15, 2021.

Where Will CRISPR Therapeutics Be in 10 Years?: https://g.foolcdn.com/editorial/images/735989/dna-sequencing-genome-science-lab.jpg
Where Will CRISPR Therapeutics Be in 10 Years?

Investor enthusiasm can wax and wane -- sometimes dramatically. Consider CRISPR Therapeutics (NASDAQ: CRSP), which is trading for around $61 a share, down from its high of $220.20 on Jan. 15, 2021.

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News:  MorphoSys to Host Virtual Investor Call with Key Opinion Leaders Focused on Pelabresib on June 21, 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys to Host Virtual Investor Call with Key Opinion Leaders Focused on Pelabresib on June 21, 2023
EQS-News: MorphoSys to Host Virtual Investor Call with Key Opinion Leaders Focused on Pelabresib on June 21, 2023
EQS-News:  MorphoSys to Host Virtual Investor Call with Key Opinion Leaders Focused on Pelabresib on June 21, 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys to Host Virtual Investor Call with Key Opinion Leaders Focused on Pelabresib on June 21, 2023
EQS-News: MorphoSys to Host Virtual Investor Call with Key Opinion Leaders Focused on Pelabresib on June 21, 2023
Why Aclaris Therapeutics Topped the Market on Tuesday: https://g.foolcdn.com/assets/images/fool/tmf-logo_400x400.png
Why Aclaris Therapeutics Topped the Market on Tuesday

Biotech investors like it when one of their companies reports gains in a developmental program, and that was the dynamic behind Tuesday's rise in the share price of Aclaris Therapeutics (NASDAQ:

Why Shares of Surmodics Soared on Tuesday: https://g.foolcdn.com/editorial/images/736202/physicians-in-a-hospital-operating-room.jpg
Why Shares of Surmodics Soared on Tuesday

Shares of Surmodics (NASDAQ: SRDX) were up 16% early Tuesday afternoon as the healthcare company, which provides chemicals for in vitro diagnostic immunoassay tests and makes coatings for

Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics?: https://g.foolcdn.com/editorial/images/735665/buy-dice.jpg
Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics?

Biotech growth stocks are inherently risky due to the plethora of competitive, financial, clinical, and regulatory hurdles unique to the industry. Despite these various risk factors, however, most

Why Manchester United Stock Is Up Today: https://g.foolcdn.com/editorial/images/736172/soccer-football-sports-adidas-nike-under-armour-getty.jpg
Why Manchester United Stock Is Up Today

A Qatari billionaire has reportedly won the auction for English Premier League club Manchester United (NYSE: MANU). The club's common shares are soaring as a result, up 10% on Tuesday morning.